Quantcast

Latest pharmaceutical industry Stories

2014-08-01 23:01:56

Market Publishers Ltd announces that in-demand Kelly Scientific Publications research reports have been added to its catalogue. London, UK (PRWEB) August 01, 2014 Market Publishers Ltd announces that in-demand Kelly Scientific Publications research reports have been added to its catalogue. Pharmaceutical Market India 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines. The key pharma...

2014-08-01 16:24:12

SOUTH PLAINFIELD, N.J., Aug. 1, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on July 31, 2014 it approved non-statutory stock options to purchase an aggregate of 67,700 shares of its common stock to seven new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of our new hires' employment compensation. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO The inducement grants were approved by PTC's...

2014-08-01 16:24:04

CHAPEL HILL, N.C., Aug. 1, 2014 /PRNewswire/ -- With monumental health reform coming into effect, the pharmaceutical industry is learning to speak a second language. Clinical efficacy is no longer the sole driver of industry success- new agencies established under the ACA like PCORI are directing roughly $1 billion a year towards outcomes research. With a variety of new entities and environments, the federal healthcare ecosystem is changing, and pharma is beginning to speak the new language...

2014-08-01 12:27:02

Persistent gender inequity at FDA has led to 26 approved drugs for men, ZERO for women WASHINGTON, Aug. 1, 2014 /PRNewswire-USNewswire/ -- In the latest call for gender equity in the approval of treatments for sexual dysfunction, more than 60 doctors and leading medical experts from across the country have penned an open letter questioning the Food and Drug Administration's (FDA) decision to approve 26 drugs marketed for the most common form of male sexual dysfunction compared with...

2014-08-01 12:26:51

Persistent gender inequity at FDA has led to 26 approved drugs for men, ZERO for women WASHINGTON, Aug. 1, 2014 /PRNewswire-USNewswire/ -- In the latest call for gender equity in the approval of treatments for sexual dysfunction, more than 60 doctors and leading medical experts from across the country have penned an open letter questioning the Food and Drug Administration's (FDA) decision to approve 26 drugs marketed for the most common form of male sexual dysfunction compared with...

2014-08-01 08:24:55

Aaron Fleishman Recognized for Dedication to Patient Advocacy and Care BOSTON, Aug. 1, 2014 /PRNewswire/ -- BBK Worldwide, a leading clinical trial marketing firm, today announced that its Head of Social Innovation and Strategic Consultation, Aaron Fleishman, was named to PharmaVOICE magazine's annual list of the 100 most inspiring people in life sciences. The award recognizes Mr. Fleishman for his contributions in helping to elevate patient volunteers in research so that their voices are...

2014-08-01 04:22:02

-- Conference Call and Webcast Scheduled for Today at 8:30 a.m. Eastern Time -- SAN DIEGO, Aug. 1, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today provided a corporate update and reported financial results for the second quarter ended June 30, 2014. "We have continued to see encouraging advancements in the US commercialization of BELVIQ, including a 43% quarter-over-quarter increase in estimated total prescriptions and estimated total per week prescriptions surpassing...

2014-07-31 23:23:14

Qutromtech has new mechanisms for treating cancer and diabetes. Yokneam, Israel (PRWEB) July 31, 2014 Qutromtech's progress in the development of biological medicine coincided with the decline of existing chemical molecules based drugs, after suffering during the last two decades competition from generic companies, including Qutromtech. However, generic competition to biological drugs is seen in the near future due to the extremely complex development processes, in addition to patent...

2014-07-31 23:18:36

The large number of FDA warning letters continually issued for improper equipment qualification is a clear sign that companies are still struggling to correctly implement this USP 1058 general chapter. During this webinar, Dr. Ludwig Huber, PhD will take attendees step-by-step through the complete qualification process and teach them how to create a bullet-proof master plan that will pass FDA scrutiny. Falls Church, VA (PRWEB) July 31, 2014 How to Implement USP 1058 for Lab Equipment...

2014-07-31 16:28:25

ATLANTA, July 31, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Danish Health and Medicines Authority has granted marketing authorization to ILUVIEN® for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related